Neopharm announced on the 7th that its operating profit for the first quarter of this year was tentatively estimated at 6.7 billion KRW, a 6.1% increase compared to the same period last year. During the same period, sales increased by 19% to 23 billion KRW. Net profit rose 6.4% to 5.7 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

